Drug Channels Institute (DCI) is a leading source of industry research about pharmaceutical economics and the drug distribution system. >

Industry Reports

The 2026 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers

The ultimate guide to the complex web of interactions within the U.S. prescription distribution and reimbursement system more >

The 2026-27 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors

The most comprehensive tool for analyzing the economic and business realities of the U.S. pharmaceutical distribution industry. more >

From The Drug Channels Blog

"How Do I Know I'm Not Just Giving Money Away?" The Question Every Market Access Leader Is Asking

Today's guest post comes from Anurati Mathur, Co-Founder & CEO at Sempre Health. Drawing on conversations with pharmaceutical market access leaders, Anurati examines whether traditional copay assistance programs are more >

Drug Channels News Roundup, October 2026: Part D’s Hidden Cost Sharing Gap, 340B’s $244 Billion Footprint, The Net Price Rebate Model, Cigna’s Wholesale Push, and Four Ways to Bag a Drug

By Bryce Platt, PharmD Fall has brought a fresh round of questions about how drug channel economics affect patients, plans, and providers. more >